Sangamo Therapeutics Inc (NAS:SGMO)
$ 2.3 0.16 (7.48%) Market Cap: 479.89 Mil Enterprise Value: 468.41 Mil PE Ratio: 0 PB Ratio: 12.23 GF Score: 47/100

Sangamo Therapeutics Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript

May 14, 2020 / 08:20PM GMT
Release Date Price: $9.83 (+2.40%)
Alexander D. Macrae
Sangamo Therapeutics, Inc. - CEO, President & Director

Good afternoon.

Aspen Mori
BofA Merrill Lynch, Research Division - Analyst

All right. Good afternoon. Okay. Sandy, okay, 1 second. Well, good afternoon, everyone. My name is Aspen Mori. I'm the U.S. biopharma tier -- team here at BofA. Welcome to day 3 of Virtual Vegas Health Care Conference, and thanks for dialing in.

I'm lucky to be joined today by the team at Sangamo and specifically have Sandy Macrae, CEO of the company, on.

Sandy, it sounds like you're there. I'll turn it over to you to do some opening remarks I understand that you'd like to share. And then maybe after that, we can squeeze into some Q&A.

Oh, and also, the slides for anyone listening are available on Sangamo's website. With that, Sandy, it's all you.

Alexander D. Macrae
Sangamo Therapeutics, Inc. - CEO, President & Director

Good afternoon, and thank you all for dialing in. These really are strange times we're in, and I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot